Jade Biosciences, Inc.
$23.5
▼
-3.31%
2026-04-21 07:38:01
jadebiosciences.com
NCM: JBIO
Explore Jade Biosciences, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.13 B
Current Price
$23.5
52W High / Low
$100.1 / $6.57
Stock P/E
—
Book Value
$6.74
Dividend Yield
0%
ROCE
-34.07%
ROE
-89.19%
Face Value
—
EPS
$-3.19
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
55
Beta
—
Debt / Equity
0.26
Current Ratio
21.09
Quick Ratio
21.09
Forward P/E
—
Price / Sales
—
Enterprise Value
$546.96 M
EV / EBITDA
-4.82
EV / Revenue
—
Rating
Strong Buy
Target Price
$28.71
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Cytokinetics, Incorporated | $65.05 | — | $8.11 B | — | -50.1% | 197.47% | $70.98 / $29.31 | $-5.37 |
| 2. | Grace Therapeutics, Inc. | $4.59 | — | $71.03 M | — | -23.81% | -10.22% | $5.18 / $2 | $4.19 |
| 3. | Recursion Pharmaceuticals, Inc. | $3.69 | — | $1.95 B | — | -48.86% | -59.54% | $7.18 / $2.8 | $2.14 |
| 4. | GeoVax Labs, Inc. | $1.17 | — | $3.38 M | — | -498.05% | -3.77% | $34.75 / $1.14 | $4.13 |
| 5. | Hoth Therapeutics, Inc. | $0.74 | — | $13.96 M | — | -200.97% | -1.91% | $2.12 / $0.49 | $0.4 |
| 6. | Crinetics Pharmaceuticals, Inc. | $40.25 | — | $4.21 B | — | -49.63% | -40.17% | $57.99 / $25.83 | $10.38 |
| 7. | Disc Medicine, Inc. | $71.41 | — | $2.74 B | — | -30.64% | -35.86% | $99.5 / $39.2 | $19.52 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | — | 0 M | 0 M |
| Operating Profit | -34.98 M | -27.4 M | -27.78 M | — | -19.98 M | -14.96 M |
| Net Profit | -31.93 M | -25.18 M | -32.13 M | — | -30.11 M | -16.28 M |
| EPS in Rs | -0.65 | -0.51 | -0.65 | -1.18 | -0.61 | -0.33 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | |
|---|---|---|
| Sales | 0 M | — |
| Operating Profit | -113.54 M | — |
| Net Profit | -127.41 M | — |
| EPS in Rs | -2.58 | — |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | |
|---|---|---|
| Total Assets | 349.78 M | 72.8 M |
| Total Liabilities | 17.26 M | 119.6 M |
| Equity | 332.52 M | -46.8 M |
| Current Assets | 348.82 M | 69.65 M |
| Current Liabilities | 16.54 M | 12 M |
Cash Flow
Last available yearly cash flow history
| 2025 | |
|---|---|
| Operating CF | -94.69 M |
| Investing CF | -247.01 M |
| Financing CF | 360.77 M |
| Free CF | -94.89 M |
| Capex | -0.2 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | |
|---|---|
| Revenue Growth % | — |
| Earnings Growth % | — |
| Profit Margin % | — |
| Operating Margin % | — |
| Gross Margin % | — |
| EBITDA Margin % | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2025-04-29 | $2.4 |
Stock Splits
| Date | Split |
|---|---|
| 2025-04-29 | 1:0.0285714 |